当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 现金流量表

共同药业

(300966)

  

流通市值:21.18亿  总市值:31.85亿
流通股本:7666.67万   总股本:1.15亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金84,433,474.74509,412,319.88371,928,026.42187,423,903.07
  收到的税费返还4,141,895.3839,222,478.8730,885,953.9927,173,040.11
  收到其他与经营活动有关的现金11,820,739.0939,052,082.29,355,868.648,253,422.63
  经营活动现金流入小计100,396,109.21587,686,880.95412,169,849.05222,850,365.81
  购买商品、接受劳务支付的现金62,915,804.23413,509,131.53291,918,645.29143,903,659.33
  支付给职工以及为职工支付的现金23,798,163.9486,527,519.0764,452,964.744,200,351.15
  支付的各项税费1,425,368.616,139,366.2116,621,189.515,757,437.99
  支付其他与经营活动有关的现金12,154,898.3340,474,473.8145,343,057.9224,781,812.17
  经营活动现金流出小计100,294,235.11546,650,490.62418,335,857.41228,643,260.64
  经营活动产生的现金流量净额101,874.141,036,390.33-6,166,008.36-5,792,894.83
二、投资活动产生的现金流量:
  收回投资收到的现金0--0
  取得投资收益收到的现金0--0
  处置固定资产、无形资产和其他长期资产收回的现金净额2,832183,709133,709133,709
  处置子公司及其他营业单位收到的现金净额0--0
  收到的其他与投资活动有关的现金0---
  投资活动现金流入小计2,832183,709133,709133,709
  购建固定资产、无形资产和其他长期资产支付的现金26,054,569.82166,326,364.17141,243,927.94115,639,950.77
  投资支付的现金0--0
  质押贷款净增加额---0
  取得子公司及其他营业单位支付的现金0--0
  支付其他与投资活动有关的现金0--0
  投资活动现金流出小计26,054,569.82166,326,364.17141,243,927.94115,639,950.77
  投资活动产生的现金流量净额-26,051,737.82-166,142,655.17-141,110,218.94-115,506,241.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金0--0
  其中:子公司吸收少数股东投资收到的现金---0
  取得借款收到的现金110,000,000468,380,787.85364,787,491.18250,918,608.07
  收到其他与筹资活动有关的现金0-49,013,137.6629,110,776.55
  筹资活动现金流入小计110,000,000468,380,787.85413,800,628.84280,029,384.62
  偿还债务支付的现金79,020,000326,064,928.71217,740,000148,390,000
  分配股利、利润或偿付利息支付的现金5,302,044.2329,831,693.8615,753,048.69,576,063.12
  其中:子公司支付给少数股东的股利、利润---0
  支付其他与筹资活动有关的现金13,969,983.3322,298,515.7751,734,496.283,030,264.52
  筹资活动现金流出小计98,292,027.56378,195,138.34285,227,544.88160,996,327.64
  筹资活动产生的现金流量净额11,707,972.4490,185,649.51128,573,083.96119,033,056.98
四、汇率变动对现金及现金等价物的影响2.94-64,040.56-43,987.3689,458.9
五、现金及现金等价物净增加额-14,241,888.34-34,984,655.89-18,747,130.7-2,176,620.72
  加:期初现金及现金等价物余额65,137,377.13100,122,033.02100,122,033.02100,122,033.02
  期末现金及现金等价物余额50,895,488.7965,137,377.1381,374,902.3297,945,412.3
补充资料:
  净利润--81,726,282.34--14,654,445.7
  资产减值准备-16,487,980.87-5,172,986.61
  固定资产和投资性房地产折旧-114,319,810.89-52,265,209.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-114,319,810.89-52,265,209.14
  无形资产摊销-1,037,899.2-557,212.56
  长期待摊费用摊销-3,327,673.59-1,653,769.38
  处置固定资产、无形资产和其他长期资产的损失-1,437,181.19-1,568,177.45
  固定资产报废损失-3,789,921.83-1,215,637.53
  公允价值变动损失--0.13--0.07
  财务费用-47,639,353.36-23,517,172.44
  投资损失-291,446.56-219,416.42
  递延所得税--24,508,060.29--9,449,316.33
  其中:递延所得税资产减少--25,479,914.25--9,612,189.63
    递延所得税负债增加-971,853.96-162,873.3
  存货的减少--99,524,102.77--55,258,045.83
  经营性应收项目的减少-25,467,407.79--44,878,873.65
  经营性应付项目的增加-34,603,579.58-31,978,578.94
  其他--1,664,120.32-271,275.62
  现金的期末余额-65,137,377.13-97,945,412.3
  减:现金的期初余额-100,122,033.02-100,122,033.02
  现金及现金等价物的净增加额--34,984,655.89--2,176,620.72
公告日期2026-04-292026-04-292025-10-282025-08-29
审计意见(境内)标准无保留意见
TOP↑